Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Oct 31 2006CORNING® CELLBIND® SURFACE USED WITH BIOLIFE SOLUTIONS’ CRYOSTOR OFFERS 58-PERCENT INCREASE IN 24-HOUR POST-PRESERVATION CELL SURVIVAL
OWEGO, NY. – Oct. 31, 2006 – BioLife Solutions Inc. (OTC BB: BLFS), a leading developer and marketer of proprietaryhypothermic storage and freeze media products for cells, tissues, and organs...
- Oct 04 2006Leading Cancer Therapy Researcher, Cryopreservation Researcher, and Regulatory Expert Join as Founding Outside Members
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading marketer of proprietary, serum and protein free hypothermic storage and cryopreservation solutions for cells and tissue at low...
- Jul 27 2006Twenty Year Med-Tech Executive to Lead Company in Emerging Market for Cryopreservation Technologies
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a developer, manufacturer, and marketer of proprietary cryopreservation solutions for cells and tissue storage and preservation at low temperatures,...
- May 17 2006
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading manufacturer and marketer of cryopreservation solutions for the preservation of cells and tissues at low temperatures, announced today...
- May 16 2006Stem Cells' Ability to Grow and Transform Into New Cells/Tissues Improved 67% With BioLife Product
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading manufacturer and marketer of cryopreservation solutions for the preservation of cells and tissues at low temperatures, announced today...
- Aug 15 2005
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it was granted a U.S. patent that covers the methods and compositions for the preservation of cells, tissues or organs in the...
- May 18 2005Orders to Commence in Second Quarter
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has entered into an exclusive manufacturing and distribution agreement with VWR International, a leader in the global research...
- Mar 04 2004
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today the settlement of a dispute between the Company and Irvine, CA-based Endocare, Inc. , arising out of Endocare's failure to register...
- Dec 03 2003$1.38 Million in Financing; $177,000 from NIH; $1.6 Million Awarded in Court Decision
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has secured $1.381 million through the sale in a private placement to investors, of Units consisting of Series G Convertible...
- Mar 03 2003
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has signed a multi-year research and development agreement with Edison, NJ-based Tissue Transformation Technologies...
- Feb 18 2003
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has reached a key milestone in its strategy to begin positioning the Company for future sales growth with the signing of a...
- Jan 22 2003New Preservation Solution Promises to Speed Development of Pioneering Cell and Tissue Engineering Therapies
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that data from a new study demonstrates that the Company's Hypothermosol® family of preservation solutions significantly extends the...
- Nov 15 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today results for its third quarter and nine months ended September 30, 2002, the first full quarter of operation since the divesture of...
- Nov 07 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at the Wall Street Analyst Forum's 46th...
- Oct 22 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at TechVest's 4th Annual Healthcare...
- Oct 21 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has selected Irvine, CA-based Allen & Caron Inc, a full-service investor and media relations firm, to support its investor,...
- Oct 16 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced that the National Institutes of Health (NIH) has awarded the Company a grant of $158,000 under the NIH's Small Business Innovation Research...
- Sep 30 2002Reflects Company's Focus as Developer and Marketer of Cell Preservation Technology to Biotechnology Industry
Cryomedical Sciences, Inc. (BULLETIN BOARD: BLFS) announced that effective September 30, 2002, the Company has changed its name to BioLife Solutions, Inc. and will begin to trade under the new...
- Jun 27 2002Board Approves Name Change to BioLife Solutions, Inc., New CEO And New Strategic Focus
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced today that it has completed the sale of its cryosurgery product line and related intellectual property assets to Irvine, CA-based...
- May 29 2002Announces New CEO, Proposed Name Change and New Strategic Focus on Proprietary Cell and Tissue Preservation Products
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced that it has executed a definitive agreement to sell its cryosurgical product line and related intellectual property assets to...
We believe the promise of cell and gene therapies starts with the integrity of a single cell
Advancing the future of cell and gene therapy
The human body can heal itself. Cell and gene therapies are designed to augment the patient’s ability to fight disease but only if the living cells behind those therapies remain viable and functional throughout the production processes. At BioLife Solutions, our mission is to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. We believe the future of cell and gene therapies hinges on the integrity of every single cell and we are here to protect that promise.
We understand the technical demands of bioprocessing in this field, and our advanced biopreservation expertise, cell culture optimization products, innovative storage systems, and closed-system manufacturing solutions are designed to enhance process efficiency, maintain cellular viability, and ensure reproducibility at every stage. Whether scaling up from R&D, navigating clinical trials or optimizing cryopreservation protocols for commercial production, we provide the tools and experience to streamline your workflow and safeguard your therapies.
Streamline workflows and safeguard therapies
GMP-COMPATIBLE
Precision
biopreservation
for
maximum
viability
GMP-COMPATIBLE
Our biopreservation media and storage solutions are engineered to maintain cell integrity and functionality. With GMP-compatible, validated formulations, we help you reduce variability and improve post-thaw recovery, ensuring robust and reproducible outcomes.
CELL VIABILITY
Best
practices
in
cell
processing
CELL VIABILITY
With deep industry experience, regulatory support, and a commitment to innovation, BioLife Solutions is dedicated to supporting bioprocess engineers in overcoming complex manufacturing challenges. Whether optimizing cryopreservation protocols or ensuring the seamless transition from lab to clinic, we are dedicated to your success.
QUALITY & COMPLIANCE
Scalable
manufacturing
and
process
optimization
QUALITY & COMPLIANCE
Enhance efficiency and consistency in your cell processing workflow with our closed-system tools for fluid management and cell processing that are automation ready. Reduce manual handling errors, improve throughput, and achieve higher standards of quality and compliance as you scale towards commercialization.
REGULATORY SUPPORT
Your
partner
in
bioprocess
optimization
REGULATORY SUPPORT
BioLife Solutions delivers specialized tools and expertise to help bioprocess engineers streamline and strengthen biopreservation processes across the cell therapy workflow. From selecting the right biopreservation media to minimizing cell loss during freezing, storage, and transports, our solutions are designed to improve consistency, reduce risk, and support a successful transition from development to clinical application.
Work with experts who understand your biopreservation challenges
Connect with
our
experts
Explore
our
solutions
Collaborative and comprehensive CDMO support
At BioLife Solutions, we partner with leading contract development and manufacturing organizations (CDMOs) to enhance their biopreservation and cell processing capabilities. By providing advanced tools, regulatory support, and process optimization strategies, we empower CDMOs to better serve therapy developers, ensuring quality, consistency, and scalability in cell therapy manufacturing.
Regulatory
readiness
Navigating the complex regulatory landscape of cell and gene therapy requires a proactive approach. BioLife Solutions offers experienced regulatory support to help prepare your biopreservation and cell processing methods to meet global standards. From IND and BLA submissions to compliance with GMP, FDA, and EMA guidelines, our solutions help streamline approval pathways.
STORE
CellSeal®
CryoCase
Alleviate CGT container challenges like fracture risk, bag burping or high rates of particulates
Data-driven
decision making
Stay ahead with our comprehensive Evidence Library, a curated collection of scientific publications, white papers, and case studies demonstrating the efficacy of BioLife Solutions’ technologies. Access peer-reviewed research, real-world application data, and expert insights to support your bioprocessing and regulatory strategies.
